The 36-month beta value for INDP is at 1.63. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for INDP is 7.48M, and currently, shorts hold a 0.46% of that float. The average trading volume for INDP on October 22, 2024 was 17.34K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
INDP) stock’s latest price update
Indaptus Therapeutics Inc (NASDAQ: INDP)’s stock price has increased by 30.48 compared to its previous closing price of 1.47. However, the company has seen a 51.02% increase in its stock price over the last five trading sessions. globenewswire.com reported 2024-05-08 that Company to present poster at American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2024 highlighting initial results from its Phase 1 clinical trial of Decoy20 Company to present poster at American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2024 highlighting initial results from its Phase 1 clinical trial of Decoy20
INDP’s Market Performance
INDP’s stock has risen by 51.02% in the past week, with a monthly rise of 49.84% and a quarterly drop of -9.53%. The volatility ratio for the week is 9.80% while the volatility levels for the last 30 days are 11.14% for Indaptus Therapeutics Inc The simple moving average for the last 20 days is 49.42% for INDP stock, with a simple moving average of -1.99% for the last 200 days.
INDP Trading at 33.45% from the 50-Day Moving Average
After a stumble in the market that brought INDP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.98% of loss for the given period.
Volatility was left at 11.14%, however, over the last 30 days, the volatility rate increased by 9.80%, as shares surge +50.82% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.60% upper at present.
During the last 5 trading sessions, INDP rose by +44.88%, which changed the moving average for the period of 200-days by +4.55% in comparison to the 20-day moving average, which settled at $1.2797. In addition, Indaptus Therapeutics Inc saw 8.98% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for INDP
Current profitability levels for the company are sitting at:
- -8547.81 for the present operating margin
- 0.29 for the gross margin
The net margin for Indaptus Therapeutics Inc stands at -8167.59. The total capital return value is set at -2.66. Equity return is now at value -127.04, with -108.73 for asset returns.
Based on Indaptus Therapeutics Inc (INDP), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -97.08. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -81.61.
Currently, EBITDA for the company is -16.38 million with net debt to EBITDA at 0.44. When we switch over and look at the enterprise to sales, we see a ratio of 5996.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.88.
Conclusion
In conclusion, Indaptus Therapeutics Inc (INDP) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
